WO2014079754A1 - Mélanges pesticides - Google Patents

Mélanges pesticides Download PDF

Info

Publication number
WO2014079754A1
WO2014079754A1 PCT/EP2013/073748 EP2013073748W WO2014079754A1 WO 2014079754 A1 WO2014079754 A1 WO 2014079754A1 EP 2013073748 W EP2013073748 W EP 2013073748W WO 2014079754 A1 WO2014079754 A1 WO 2014079754A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
compound
mixtures
chloro
phenyl
Prior art date
Application number
PCT/EP2013/073748
Other languages
English (en)
Inventor
Lutz Brahm
Burghard Liebmann
Ronald Wilhelm
Markus Gewehr
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2014079754A1 publication Critical patent/WO2014079754A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to synergistic mixtures comprising as active components
  • -Inhibitors of complex III at Qo site e.g. strobilurins: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxy- strobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, py- raclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxy- methyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-di-chlorophenyl)- 1 -methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methyl-acetamide, pyri- bencarb,
  • -inhibitors of complex II e. g. carboxamides: benodanil, bixafen, boscalid, carboxin, fen- furam, fluopyram, flutolanil, fluxapyroxad, furametpyr, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4'-trifluoromethylthiobi- phenyl-2-yl)-3-difluoromethyl-1 -methyl-1 H pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl- butyl)-phenyl)-1 ,3-dimethyl-5-fluoro-1 H-pyrazole-4-carboxamide, N-[9-(dichloromethylene)-
  • respiration inhibitors e.g. complex I, uncouplers: diflumetorim, (5,8-difluoro-quin- azolin-4-yl)- ⁇ 2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl ⁇ -amine; nitro- phenyl derivates: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctra- din; and silthiofam; B) Sterol biosynthesis inhibitors (SBI fungicides)
  • SBI fungicides Sterol biosynthesis inhibitors
  • DMI fungicides triazoles: azaconazole, bitertanol, bromu- conazole, cyproconazole, difenoconazole,diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ip- conazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, pro- piconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, tri- adimenol, triticonazole, uniconazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)
  • -Delta14-reductase inhibitors aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;
  • -phenylamides or acyl amino acid fungicides benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, ofurace, oxadixyl;
  • -tubulin inhibitors such as benzimidazoles, thiophanates: benomyl, carbendazim, fuber- idazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7-(4-methyl- piperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine;
  • -methionine synthesis inhibitors anilino-pyrimidines: cyprodinil, mepanipyrim, pyrimetha- nil;
  • blasticidin-S blasticidin-S, kasugamycin, kasugamycin hydrochloride- hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;
  • -MAP / histidine kinase inhibitors fluoroimid, iprodione, procymidone, vinclozolin, fen- piclonil, fludioxonil;
  • -G protein inhibitors quinoxyfen
  • -Phospholipid biosynthesis inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane;
  • -lipid peroxidation dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
  • -organochlorine compounds e.g. phthalimides, sulfamides, chloronitriles: anilazine, chlo- rothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pen- tachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4- methyl-benzenesulfonamide;
  • phthalimides e.g. phthalimides, sulfamides, chloronitriles
  • guanidines and others guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
  • glucan synthesis validamycin, polyoxin B; melanin synthesis inhibitors: py- roquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;
  • Ampelomyces quisqualis e.g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany
  • Aspergillus flavus e.g. AFLAGUARD® from Syngenta, CH
  • Aureobasidium pullulans e.g. BOTECTOR® from bio-ferm GmbH, Germany
  • Bacillus pumilus e.g. NRRL Accession No. B-30087 in SONATA® and BALLAD® Plus from AgraQuest Inc., USA
  • Bacillus sub- tilis e.g. isolate NRRL-Nr.
  • Clonostachys rosea f. catenulata also named Gliocladium catenulatum (e.g. isolate J1446: PRESTOP® from Verdera, Finland), Coniothyrium minitans (e.g. CONTANS® from Prophyta, Germany), Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g. YIELD PLUS® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (e.g.
  • BIO- FOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France
  • Metschnikowia fructicola e.g. SHEMER® from Agrogreen, Israel
  • Microdochium dimerum e.g. ANTIBOT® from Agrauxine, France
  • Phlebiopsis gigantea e.g. ROTSOP® from Verdera, Finland
  • Pseudozyma flocculosa e.g. SPORODEX® from Plant Products Co. Ltd., Canada
  • Pythium oligandrum DV74 e.g.
  • harzianum TH 35 e.g. ROOT PRO® from Mycontrol Ltd., Israel
  • T. harzianum T-39 e.g. TRICHODEX® and TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel
  • T. harzianum and T. viride e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ
  • T. harzianum ICC012 and T. viride ICC080 e.g. REMEDIER® WP from Isagro Ricerca, Italy
  • T. polysporum and T. harzianum e.g. BINAB® from BINAB Bio-Innovation AB, Sweden
  • T. virens GL-21 e.g. SOIL- GARD® from Certis LLC, USA
  • T. viride e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes & Co. Ltd., Indien
  • T. viride TV1 e.g. T. viride TV1 from Agribiotec srl, Italy
  • Ulocladium oudemansii HRU3 e.g. BOTRY-ZEN® from Bot ry-Zen Ltd, NZ
  • BOTRY-ZEN® from Bot ry-Zen Ltd, NZ
  • insecticidal compound IB selected from the group consisting of
  • M-1 A acetylcholine esterase inhibitors from the class of carbamates: aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosul- fan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, metho- myl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xy- lylcarb, and triazamate;
  • fiproles phenylpyrazoles: ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
  • M-3 sodium channel modulators from the class of pyrethroids acrinathrin, allethrin, d-cis- trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bio- resmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gam- ma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenval
  • M-4 nicotinic acteylcholine receptor agonists from the class of neonicotinoids: acetamiprid, chlothianidin, cycloxaprid, dinotefuran, flupyradifurone, imidacloprid, nitenpyram, sul- foxaflor, thiacloprid, thiamethoxam or the compound 1 -[(6-chloro-3-pyridyl)methyl]-7-me- thyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1 ,2-a]pyridine (known from
  • M-7 juvenile hormone mimics hydroprene, kinoprene, methoprene, fenoxycarb or pyriproxyfen;
  • M-8 non-specific multi-site inhibitors methyl bromide and other alkyl halides, chloropicrin, sulfuryl fluoride, borax or tartar emetic;
  • M-9 selective homopteran feeding blockers pymetrozine, flonicamid, pyrifluquinazon, 2-(5- fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride
  • M-10 mite growth inhibitors clofentezine, hexythiazox, diflovidazin or etoxazole;
  • M-1 1 inhibitors of mitochondrial ATP synthase diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, or tetradifon; M-12 uncouplers of oxidative phosphorylation: chlorfenapyr, DNOC, or sulfluramid;
  • M-13 nicotinic acetylcholine receptor channel blockers bensultap, cartap hydrochloride, thiocyclam, thiosultap sodium;
  • M-14 inhibitors of the chitin biosynthesis type 0 bistrifluron, chlor- fluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron;
  • M-15 inhibitors of the chitin biosynthesis type 1 buprofezin;
  • M-16 moulting disruptors cyromazine
  • M-17 Ecdyson receptor agonists methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
  • Mitochondrial complex III electron transport inhibitors hydramethylnon, acequinocyl, flometoquin, fluacrypyrim or pyriminostrobin;
  • M-20 Mitochondrial complex I electron transport inhibitors fenazaquin, fenpyroximate, py- rimidifen, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim, or rotenone;
  • M-23 Mitochondrial complex II electron transport inhibitors cyenopyrafen, cyflumetofen or pyflubumide;
  • M-24 Ryanodine receptor-modulators from the class of diamides flubendiamide, chlorantraniliprole (rynaxypyr), cyantraniliprole (cyazypyr), (R)-3-chloro-N1 - ⁇ 2-methyl-4- [1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl ⁇ -N2-(1 -methyl-2- methylsulfonylethyl)phthalamide or (S)-3-chloro-N1 - ⁇ 2-methyl-4-[1 ,2,2,2-tetrafluoro-1 - (trifluoromethyl)ethyl]phenyl ⁇ -N2-(1 -methyl-2-methylsulfonylethyl)phthalamide (both known from WO 2007/101540), 3-bromo-N- ⁇ 2-bromo-4-chloro-6-[(1 - cyclopropylethyl)carbamoyl]pheny
  • one compound IC having plant growth regulator activity selected from the group consisting of:
  • Antiauxins clofibric acid, 2,3,5-tri-iodobenzoic acid;
  • Ethylene modulators aviglycine, 1 -methylcyclopropene (1 -MCP), prohexadione, prohexa- dione calcium, trinexapac, trinexapac-ethyl; - Ethylene releasers: ACC, et reviewingl, ethephon, glyoxime;
  • abscisic acid abscisic acid, ancymidol, butralin, carbaryl, chlorphonium, chlorprop- ham, dikegulac, flumetralin, fluoridamid, fosamine, glyphosine, isopyrimol, jasmonic acid, maleic hydrazide, mepiquat, mepiquat chloride, mepiquat pentaborate, piproctanyl, prohy- drojasmon, propham, 2,3,5-tri-iodobenzoic acid;
  • chlormequat chlormequat chloride, daminozide, flurprimidol, mefluid- ide, paclobutrazol, tetcyclacis, uniconazole, metconazole;
  • Unclassified plant growth regulators / classification unknown amidochlor, benzofluor, buminafos, carvone, choline chloride, ciobutide, clofencet, cloxyfonac, cyanamide, cyclanilide, cycloheximide, cyprosulfamide, epocholeone, ethychlozate, ethylene, fenrida- zon, fluprimidol, fluthiacet, heptopargil, holosulf, inabenfide, karetazan, lead arsenate, methasulfocarb, pydanon, sintofen, triapenthenol;
  • Preferred Azospirillum spp. are Azospirillum brasilense, Azospirillum brasilense strain BR 1 1005 (SP 245), Azospirillum lipoferum, Azospirillum amazonense, Azospirillum irakense and Azospirillum halopraeferens.
  • Azospirillum spp. are Azospirillum amazonense BR 1 1 140 (SpY2T; deposited with EMBRAPA, Brazil), A. brasilense AZ39, A. brasilense BR 1 1002, A. brasilense XOH and A. lipoferum BR 1 1646 (Sp31 ).
  • Azospirillum spp. are also selected from Azospirillum brasilense, preferably from A. brasilense BR 1 1005 (SP 245), A. brasilense AZ39, A. brasilense XOH and A. brasilense BR 1 1002.
  • Azospirillum spp. are selected from A. lipoferum, preferably being strain A. lipoferum BR 1 1646 (Sp31 ), which is deposited with EMBRAPA, Brazil.
  • Azospirillum spp. are known and available (some even commercially) in the public domain.
  • Azospirillum brasilense strain BR 1 1005 (SP 245) is commercially available from Becker Underwood, Nitral Urbana Laboratrios Ltda., BR, now BASF Agricultural Specialties Ltd., BRAZIL (Product: Gelfix Gramineas) and is deposited with EMBRAPA, Brazil.
  • Azospirillum brasilense XOH is known from product AZOS from Xtreme Gardening, USA USA or RTI Refor- estation Technologies International; USA.
  • brasilense BR 1 102 is deposited with EMBRAPA, Brazil. Further Azospirillum strains are obtainable from EMBRAPA, Brazil.
  • Bacillus subtilis MBI600 (herein defined as compound ID) having the accession number NRRL B-50595 is deposited with the United States Department of Agriculture on Nov. 10, 201 1 under the strain designation Bacillus subtilis 1430. It has also been deposited at The National Collections of Industrial and Marine Bacteria Ltd. (NCIB), Torry Research Station, P.O. Box 31 , 135 Abbey Road, Aberdeen, AB9 8DG, Scotland under accession number 1237 on December 22, 1986. Bacillus subtilis MBI600 is known as plant growth-promoting rice seed treatment from Int. J. Microbiol. Res. ISSN 0975-5276, 3(2) (201 1 ), 120-130 and further described e.g. in US 2012/0149571 A1. This strain MBI600 is commercially available as liquid formulation product Integral® (Becker-Underwood Inc., USA).
  • Bacillus amyloliquefaciens Several plant-associated strains of the genus Bacillus have been described as belonging to the species Bacillus amyloliquefaciens or Bacillus subtilis are used commercially to promote the growth and improve the health of crop plants (Phytopathology 96, 145-154, 2006). Recently, the strain MBI 600 has been re-classified as Bacillus amyloliquefaciens subsp. plantarum based on polyphasic testing which combines classical microbiological methods relying on a mixture of traditional tools (such as culture-based methods) and molecular tools (such as genotyping and fatty acids analysis).
  • Bacillus subtilis MBI600 (or MBI 600 or MBI-600) is identical to Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600.
  • Bacillus subitilis MBI 600 shall mean Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600.
  • Bacillus amyloliquefaciens and/or Bacillus subitlis are naturally occurring spore- forming bacteria found e.g. in soils or on plant surfaces all over the world.
  • the Bacillus subtilis strain MBI600 was isolated from a faba bean plant leaf surface growing at Nottingham Universi- ty School of Agriculture, Sutton Bonington, United Kingdom.
  • Bacillus subtilis MBI 600 were cultivated using media and fermentation techniques known in the art, e.g. in Tryptic Soy Broth (TSB) at 27°C for 24-72 hrs.
  • the bacterial cells can be washed and concentrated (e.g. by centrifugation at room temperature for 15 min at 7000 x g).
  • bacterial cells preferably spores were suspend- ed in a suitable dry carrier (e.g. clay).
  • a suitable liquid carrier e.g. water-based
  • the spore density number of spores per mL was determined by identifying the number of heat- resistant colony-forming units (70°C for 10 min) on Trypticase Soy Agar after incubation for 18- 24 hrs at 37°C.
  • Bacillus subtilis MBI 600 is active in temperatures between 7°C and 52°C (Holtmann, G. & Bremer, E. (2004), J. Bacteriol. 186, 1683-1693).
  • Bacillus pumilus INR-7 (defined herein as compound ID) is also otherwise referred to as BUF- 22 or as BU F-33 or similar codes and has been described e.g. in US 2012/0149571 A1 .
  • Bacillus pumilus INR7 is dseposited as BUF-22 having the accession number NRRL B-50153 with the United States Department of Agriculture on Jul. 23, 2008, and as BU F-33, having the accession number NRRL B-50185 with the United States Department of Agriculture on Oct. 15, 2008.
  • Bacillus pumilus INR7 can be cultivated and prepared as described for Bacillus subtilis MBI 600.
  • Bacillus simplex strain ABU 288 (defined herein as compound II) having the accession number NRRL B-50340 is deposited with the United States Department of Agriculture on Jan. 19, 2010. Bacillus simplex ABU 288 can be cultivated and prepared as described for Bacillus subtilis MBI 600.
  • Trichoderma fertile strain JM41 R (herein defined as compound II) is known from commercially available from Becker Underwood AgBio SA (Pty) Ltd, South Africa (now BASF Agricultural Specialties Ltd, South Africa) as product Tricho PlusTM (2x 10 9 conidia per g powder). JM41 R having the accession number NRRL-50759 chas further been deposited with the United States Department of Agriculture on June 8, 2012. This strain is known to control Pythium wilt and root rot in hydroponically growth lettuce (J. Boshoff M.Sc. thesis of University of Pretoria, Pretoria, South Africa, October 2005).
  • the present invention relates to synergistic mixtures comprising Azospirillum brasilense, and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum bra- silense strain BR 1 1005 (SP 245) and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum lipoferum, and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ama- zonense, and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ira- kense and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum halo- praeferens and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense AZ39 and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense BR 1 1002 and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound IA.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IA.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum bra- silense, and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum bra- silense strain BR 1 1005 (SP 245) and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum lipoferum, and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum ama- zonense, and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum ira- kense and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum halo- praeferens and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound IB
  • the present invention furthermore relates o synergistic mixtures comprising A. brasilense AZ39 and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising A. brasilense BR 1 1002 and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising A. brasilense XOH and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IB.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum bra- silense, and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum bra- silense strain BR 1 1005 (SP 245) and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum lipoferum, and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum ama- zonense, and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum ira- kense and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising Azospirillum halo- praeferens and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound IC
  • the present invention furthermore relates o synergistic mixtures comprising A. brasilense AZ39 and one compound IC.
  • the present invention furthermore relates o synergistic mixtures comprising A. brasilense BR 1 1002 and one compound IC.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound IC.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IC.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense, and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense strain BR 1 1005 (SP 245) and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum lipoferum, and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ama- zonense, and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ira- kense and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum halo- praeferens and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense AZ39 and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense BR 1 1002 and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound ID.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound ID.
  • pests embrace animal pests, and harmful fungi.
  • Another problem encountered concerns the need to have available pest control agents which are effective against a broad spectrum of pests, e.g. both animal pests and harmful fungi.
  • pest control agents that combine knock-down activity with prolonged control, that is, fast action with long lasting action.
  • Another difficulty in relation to the use of pesticides is that the repeated and exclusive applica- tion of an individual pesticidal compound leads in many cases to a rapid selection of pests, that means animal pests, and harmful fungi, which have developed natural or adapted resistance against the active compound in question. Therefore there is a need for pest control agents that help prevent or overcome resistance.
  • Another problem underlying the present invention is the desire for compositions that improve plants, a process which is commonly and hereinafter referred to as "plant health”.
  • the action of the inventive mixtures goes far beyond the fungicidal and/or insecticidal and/or plant health improving action of the active compounds I present in the mixture alone (synergism).
  • insecticidal or “insect attac” also denotes not only action against (or attac by) insects, but also against (by) arachnids and nematodes.
  • the present invention relates to the inventive mixtures having synergistically enhanced action of controlling harmful fungi.
  • the invention relates to a method for controlling pest, using the inventive mixtures having synergistically enhanced action for controlling pests and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate seed treatment or soil application.
  • the present invention relates inventive mixtures having synergistically enhanced action of increasing the health of plants.
  • the invention relates to a method for improving the health of plants, using the inventive mixtures having synergistically enhanced action for improving the health of plants and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate seed treatment or or soil application.
  • the present invention relates to a method for protection of plant propagation material from pests and/or improving the health of plants, wherein the plant propagation material is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from pests, wherein the plant propagation material is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from animal pests (insects, acarids or nematodes), wherein the plant propagation material are treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from harmful fungi, wherein the plant propagation material is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for improving the health of plants grown from said plant propagation material, wherein the plant propagation material is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from pests and/or improving the health of plants grown from said plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from pests, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from harmful fungi, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for protection of plant propagation material from animal pests (insects, acarids or nematodes), wherein the soil, wherein plant propaga- tion material is sown, is treated with an effective amount of an inventive mixture.
  • the present invention relates to a method for improving the health of plants grown from plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
  • the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
  • plant propagation material is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil.
  • The- se young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.
  • the term propagation material denotes seeds.
  • pesticidally effective amount means the amount of the inventive mixtures or of compositions comprising the mixtures needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism.
  • the pesticidally effective amount can vary for the various mixtures / compositions used in the invention.
  • a pesticidally effective amount of the mixtures / compositions will also vary according to the prevailing condi- tions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like.
  • plant health effective amount denotes an amount of the inventive mixtures, which is sufficient for achieving plant health effects as defined herein below. More exemplary information about amounts, ways of application and suitable ratios to be used is given below. Again, the skilled artisan is well aware of the fact that such an amount can vary in a broad range and is dependent on various factors, e.g. the treated cultivated plant or material and the climatic conditions. Healthier plants are desirable since they result among others in better yields and/or a better quality of the plants or crops, specifically better quality of the harvested plant parts. Healthier plants also better resist to biotic and/or abiotic stress. A high resistance against biotic stresses in turn allows the person skilled in the art to reduce the quantity of pesticides applied and consequently to slow down the development of resistances against the respective pesticides.
  • health of a plant or “plant health” is defined as a condition of the plant and/or its products which is determined by several aspects alone or in combination with each other such as increased yield, plant vigor, quality of harvested plant parts and tolerance to abiotic and/or biotic stress.
  • Each plant health indicator listed below which is selected from the groups consisting of yield, plant vigor, quality and tolerance of the plant to abiotic and/or biotic stress, is to be understood as a preferred embodiment of the present invention either each on its own or preferably in combination with each other.
  • "increased yield" of a plant means that the yield of a product of the respective plant is increased by a measurable amount over the yield of the same product of the plant produced under the same conditions, but without the application of the inventive mixture.
  • increased yield can be characterized, among others, by the following improved properties of the plant:
  • the yield is increased by at least 4%.
  • the yield increase may even be higher, for example 5 to 10 %, more preferable by 10 to 20 %, or even 20 to 30 %
  • the yield - if measured in the absence of pest pressure - is increased by at least 2 %
  • the yield increase may even be higher, for example until 4%-5% or even more.
  • Another indicator for the condition of the plant is the plant vigor.
  • the plant vigor becomes manifest in several aspects such as the general visual appearance.
  • improved plant vigor can be characterized, among others, by the following improved properties of the plant: improved vitality of the plant; and/or im- proved plant growth; and/or improved plant development; and/or improved visual appearance; and/or improved plant stand (less plant verse/lodging); and/or improved emergence; and/or enhanced root growth and/or more developed root system; and/or enhanced nodulation, in particular rhizobial nodulation;-and/or increased plant height; and/or increased tiller number; and/or increased number of side shoots; and/or increased number of flowers per plant; and/or in- creased shoot growth;-and/or less non-productive tillersand/or less input needed (such as fertilizers or water); and/or less seeds neededf and/or stronger and/or more productive tillersand/or improved quality of seeds (for being seeded in the following seasons for seed production); and/or field establishment.
  • Another indicator for the condition of the plant is the "quality" of a plant and/or its products.
  • enhanced quality means that certain plant characteristics such as the content or composition of certain ingredients are increased or improved by a measurable or noticeable amount over the same factor of the plant produced under the same conditions, but without the application of the mixtures of the present invention.
  • Enhanced quality can be char- acterized, among others, by following improved properties of the plant or its product: increased nutrient content; and/or increased protein content; and/or increased oil content; and/or increased starch content; and/or increased content of fatty acids; and/or increased metabolite content; and/or increased carotenoid content; and/or increased sugar content; and/or increased amount of essential amino acids; and/or improved nutrient composition; and/or improved protein composition; and/or improved composition of fatty acids; and/or improved metabolite composition; and/or improved carotenoid composition; and/or improved sugar composition; and/or improved amino acids composition ; and/or improved or optimal fruit color; and/or improved leaf color; and/or higher storage capacity; and/or better processability of the harvested products.
  • Another indicator for the condition of the plant is the plant's tolerance or resistance to biotic and/or abiotic stress factors. Biotic and abiotic stress, especially over longer terms, can have harmful effects on plants.
  • Biotic stress is caused by living organisms while abiotic stress is caused for example by environmental extremes.
  • "enhanced tolerance or resistance to biotic and/or abiotic stress factors” means (1 .) that certain negative factors caused by biotic and/or abiotic stress are diminished in a measurable or noticeable amount as compared to plants exposed to the same conditions, but without being treated with an inventive mixture and (2.) that the negative effects are not diminished by a direct action of the inventive mixture on the stress factors, e.g. by its fungicidal or insecticidal action which directly destroys the microorganisms or pests, but rather by a stimulation of the plants' own defensive reactions against said stress factors.
  • Negative factors caused by biotic stress such as pathogens and pests are widely known and are caused by living organisms, such as competing plants (for example weeds), microorganisms (such as phythopathogenic fungi and/or bacteria) and/or viruses.
  • Negative factors caused by abiotic stress are also well-known and can often be observed as reduced plant vigor (see above), for example:
  • Abiotic stress can be caused for example by: extremes in temperature such as heat or cold
  • heat stress / cold stress and/or strong variations in temperature; and/or temperatures unusual for the specific season; and/or drought (drought stress); and/or extreme wetness; and/or high salinity (salt stress); and/or radiation (for example by increased UV radiation due to the decreasing ozone layer); and/or increased ozone levels (ozone stress); and/or organic pollution (for ex- ample by phythotoxic amounts of pesticides); and/or inorganic pollution (for example by heavy metal contaminants).
  • the above identified indicators for the health condition of a plant may be interdependent and may result from each other.
  • an increased resistance to biotic and/or abiotic stress may lead to a better plant vigor, e.g. to better and bigger crops, and thus to an increased yield.
  • a more developed root system may result in an increased resistance to biotic and/or abiotic stress.
  • these interdependencies and interactions are neither all known nor fully understood and therefore the different indicators are described sepa- rately.
  • inventive mixtures effectuate an increased yield of a plant or its product.
  • inventive mixtures effectuate an increased vigor of a plant or its product.
  • inventive mixtures effectuate in an increased quality of a plant or its product. In yet another embodiment the inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against biotic stress.
  • inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against abiotic stress.
  • the inventive mixtures effect an increase in the yield.
  • the inventive mixtures effect an improvement of the plant vigor.
  • the plant health effects of the inventive mixtures effect increased resistance of plant against biotic stress. In another preferred embodiment of the invention, the plant health effects of the inventive mixtures effect increased resistance of plant against abiotic stress.
  • the inventive mixtures effect an increase in the yield.
  • the inventive mixtures effect an increase in the vigor.
  • the mass ratio of of any two ingredients in each combination is selected as to give the desired, for example, synergistic action. In general, the mass ratio would vary depending on the specific compound I.
  • the ratio by weight between any two ingredients in any combination of the present invention (compound I: compound II) [in the ternary mixtures ratios between any of the compounds I, II and III], independently of one another, is from 1000:1 to 1 :1000, preferably from 500:1 to 1 :500, more preferably the ratios from 100:1 to 1 :100 (for example ratios from 99:1 , 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8, 91 :9, 90:10, 89:1 1 , 88:12, 87:13, 86:14, 85:15, 84:16, 83:17, 82:18, 81 :19, 80:20, 79:21 , 78:22, 77:23, 76:24, 75
  • preferred mass ratios are those between any two components of present invention are from 75:1 to 1 :75, more preferably, 50:1 to 1 .50, especially 25:1 to 1 :25, advantageously 10:1 to 1 :10, such as 5:1 to 1 :5.
  • compound II may be supplied in any physiological state such as active or dormant.
  • Dormant compound II may be supplied for example frozen, dried, or lyophilized or partly desic- cated (procedures to produce these partly desiccated organisms are given in WO 2008/002371 ) or for compound ID in form of spores.
  • Organisms in an active state can be delivered in a growth medium without any additional additives or materials or in combination with suitable nutrient mixtures.
  • the compound II is preferably delivered and formulated in a dormant stage.
  • the microorganisms as used according to the invention can be cultivated continuously or discontinuously in the batch process or in the fed batch or repeated fed batch process.
  • a review of known methods of cultivation will be found in the textbook by Chmiel (Bioreaktoren und periphere bamboo (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
  • the culture medium that is to be used must satisfy the requirements of the particular strains in an appropriate manner.
  • culture media for various microorganisms are given in the handbook "Manual of Methods for General Bacteriology” of the American Society for Bacte- riology (Washington D. C, USA, 1981 ).
  • These culture media that can be used according to the invention generally comprise one or more sources of carbon, sources of nitrogen, inorganic salts, vitamins and/or trace elements.
  • Preferred sources of carbon are sugars, such as mono-, di- or polysaccharides.
  • Very good sources of carbon are for example glucose, fructose, man- nose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or cellu- lose.
  • Sugars can also be added to the media via complex compounds, such as molasses, or other by-products from sugar refining. It may also be advantageous to add mixtures of various sources of carbon.
  • Other possible sources of carbon are oils and fats such as soybean oil, sun- flower oil, peanut oil and coconut oil, fatty acids such as palmitic acid, stearic acid or linoleic acid, alcohols such as glycerol, methanol or ethanol and organic acids such as acetic acid or lactic acid.
  • Sources of nitrogen are usually organic or inorganic nitrogen compounds or materials containing these compounds.
  • sources of nitrogen include ammonia gas or ammonium salts, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea, amino acids or complex sources of nitrogen, such as corn-steep liquor, soybean flour, soybean protein, yeast extract, meat extract and others.
  • the sources of nitrogen can be used separately or as a mixture.
  • Inorganic salt compounds that may be present in the media comprise the chloride, phosphate or sulfate salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron.
  • Inorganic sulfur-containing compounds for example sulfates, sulfites, dithionites, tetrathi- onates, thiosulfates, sulfides, but also organic sulfur compounds, such as mercaptans and thiols, can be used as sources of sulfur.
  • Phosphoric acid, potassium dihydrogenphosphate or dipotassium hydrogenphosphate or the corresponding sodium-containing salts can be used as sources of phosphorus.
  • Chelating agents can be added to the medium, in order to keep the metal ions in solution.
  • Especially suitable chelating agents comprise dihydroxyphenols, such as catechol or protocatechuate, or organic acids, such as citric acid.
  • the culture media used may also contain other growth factors, such as vitamins or growth promoters, which include for example biotin, riboflavin, thiamine, folic acid, nicotinic acid, pantothenate and pyridoxine. Growth factors and salts often come from complex components of the media, such as yeast extract, molasses, corn-steep liquor and the like. In addition, suitable precursors can be added to the culture medium. The precise composition of the compounds in the medium is strongly dependent on the particular experiment and must be decided individually for each specific case. Information on media optimization can be found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Publ. P.M. Rhodes, P.F. Stanbury, IRL Press (1997) p.
  • Growing media can also be obtained from commercial suppliers, such as Standard 1 (Merck) or BHI (Brain heart infusion, DIFCO) etc. All components of the medium are sterilized, either by heating (20 min at 2.0 bar and 121 °C) or by sterile filtration. The components can be sterilized either together, or if necessary separately. All the components of the medium can be present at the start of growing, or optionally can be added continuously or by batch feed.
  • the temperature of the culture of the respective microorganism is normally between 15°C and 45°C, preferably 25°C to 40°C and can be kept constant or can be varied during the experiment.
  • the pH value of the medium should be in the range from 5 to 8.5, preferably around 7.0.
  • the pH value for growing can be controlled during growing by adding basic compounds such as sodium hydroxide, potassium hydroxide, ammonia or ammonia water or acid compounds such as phosphoric acid or sulfuric acid.
  • Antifoaming agents e.g. fatty acid polyglycol esters, can be used for controlling foaming.
  • suitable substances with selective action e.g. antibiotics
  • Oxygen or oxygen-containing gas mixtures e.g. the ambient air, are fed into the culture in order to maintain aerobic conditions.
  • the temperature of the culture is normally from 20°C to 45°C. Culture is continued until a maximum of the desired product has formed. This is normally achieved within 10 hours to 160 hours.
  • the cells can be disrupted optionally by high-frequency ultrasound, by high pressure, e.g. in a French pressure cell, by osmolysis, by the action of detergents, lytic enzymes or organic solvents, by means of homogenizers or by a combination of several of the methods listed.
  • the methodology of the present invention can further include a step of recovering individual compositions such as cell-free extracts, supernatants, metabolites or alike.
  • the term "recovering" includes extracting, harvesting, isolating or purifying of an extract, supernatant or metabolite e.g. from whole culture broth.
  • Recovering can be performed according to any conventional isolation or purification methodology known in the art including, but not limited to, treatment with a conventional resin (e.g., anion or cation exchange resin, non-ionic adsorption resin, etc.), treatment with a conventional adsorbent (e.g., activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.), alteration of pH, solvent extraction (e.g., with a conventional solvent such as an alcohol, ethyl acetate, hexane and the like), distillation, dialysis, filtration, concentration, crystallization, recrystallization, pH adjustment, lyophilization and the like.
  • a conventional resin e.g., anion or cation exchange resin, non-ionic adsorption resin, etc.
  • a conventional adsorbent e.g., activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.
  • solvent extraction e.g.
  • the agent can be recovered from culture media by first removing the microorganisms. The remaining broth is then passed through or over a cation exchange resin to remove unwanted cations and then through or over an anion exchange resin to remove unwanted inorganic anions and organic acids.
  • Preferred inventive mixtures are those comprising compound II and fungicidal compound IA selected from the group consisting of
  • Inhibitors of complex III at Qo site e.g. strobilurins: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3- methoxy-acrylic acid methyl ester and 2 (2-(3-(2,6-di-chlorophenyl)-1 -methyl- allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methyl-acetamide, pyribencarb, triclopy- ricarb/chlor
  • inhibitors of complex III at Qi site cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3- [(3-acetoxy-4 methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2 methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2 car- bonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2 methylpropanoate, [(3S,6S,7R,8R)-8- benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2 carbonyl)amino]-6-methyl-4,9-dioxo
  • inhibitors of complex II e. g. carboxamides: flutolanil, bixafen, boscalid, carboxin, fluopy- ram, fluxapyroxad, isopyrazam, oxycarboxin, penflufen, penthiopyrad, sedaxane, N-(4'- trifluoromethylthiobiphenyl-2-yl)-3 difluoromethyl-1-methyl-1 H pyrazole-4-carboxamide, N-(2- (1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-dimethyl-5 fluoro-1 H-pyrazole-4 carboxamide, N-[9-
  • complex II e. g. carboxamides: flutolanil, bixafen, boscalid, carboxin, fluopy- ram, fluxapyroxad, isopyrazam, oxycarboxin, penflufen, penthiopyrad, sedax
  • respiration inhibitors e.g. complex I, uncouplers: (5,8-difluoroquinazolin-4-yl)- ⁇ 2-[2- fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl ⁇ -amine, fluazinam; ametoctradin; and silthiofam;
  • DMI fungicides triazoles: bitertanol, cyproconazole, difeno- conazole,diniconazole, diniconazole-M, epoxiconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, ipconazole, metconazole, myclobutanil, propiconazole, prothio-conazole, sime- conazole, tebuconazole, tetraconazole, triadimenol, triticonazole,
  • Delta14-reductase inhibitors fenpropimorph, spiroxamine
  • phenylamides or acyl amino acid fungicides benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, ofurace, oxadixyl;
  • tubulin inhibitors such as benzimidazoles, thiophanates: benomyl, carbendazim, fuber- idazole, thiabendazole, thiophanate-methyl;
  • methionine synthesis inhibitors anilino-pyrimidines: cyprodinil, pyrimethanil;
  • MAP / histidine kinase inhibitors iprodione, fludioxonil;
  • Phospholipid biosynthesis inhibitors probenfos
  • lipid peroxidation quintozene, tolclofos-methyl, etridiazole;
  • inorganic active substances Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur; thio- and dithiocarbamates: mancozeb, maneb, metiram, thiram;
  • organochlorine compounds e.g. phthalimides, sulfamides, chloronitriles: chlorothalonil, captan, folpet;
  • guanidines and others dodine, guazatine, guazatine-acetate, iminoctadine, iminoctadine- triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6- c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
  • inhibitors of glucan synthesis validamycin
  • melanin synthesis inhibitors pyroquilon, tricy- clazole
  • Preferred inventive mixtures especially useful for seed treatment are those comprising compound II and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Boscalid, Fluoxapyroxad, Fluopyram, Penflufen, Benzovindiflupyr, Sedaxane, Penthiopyrad, Difenoconazole, Fluquinconazole, Triticonazole, Tebuconazole, Tetraconazole, Hexaconazole, Thiophanate-methyl, Pyrimethanil, Cyrodinil, Metalaxyl, Dimethomorph and Mandiprpamid; more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Boscalid, Fluoxapyroxad, Fluopyram, Penflufen, Benzovindiflupyr, Sedaxane, Penthiopyrad, Difen
  • Preferred inventive mixtures especially useful for soil treatment are those comprising compound II and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin,
  • Picoxystrobin Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl, Fludioxonil, Oryzastro- bin, Boscalid, Penthiopyrad, Iprodione, Dimethomorph and Mandipropamid, more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl and Fludioxonil.
  • Equally preferred inventive mixtures are those comprising compound II and one inseciticdal compound IB selected from the group consisting of
  • aldicarb for example aldicarb, benfuracarb, carbofuran, carbosulfan, isoprocarb, methiocarb, methomyl, oxamyl, pirimicarb, thiodicarb, triazamate;
  • acephate for example acephate, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, diazinon, dichlorvos/ DDVP, dimethoate, disulfoton, ethoprophos, fenami- phos, fenitrothion, fosthiazate, imicyafos, isofenphos, isoxathion, methamidophos, phorate, phoxim, pirimiphos- methyl, profenofos, tebupirimfos, terbufos;
  • ethiprole for example ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
  • acrinathrin for example acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenvalerate, flucythrinate, permethrin, silafluofen, tefluthrin;
  • abamectin for example abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
  • M-9 selective homopteran feeding blockers for example pymetrozine, pyrifluquinazon, 2-(5-fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2- pyridyl)thiazole hydrofluoride
  • chlorfenapyr for example chlorfenapyr
  • diflubenzuron for example diflubenzuron, flufenoxuron, lufenuron, novaluron, teflubenzuron;
  • buprofezin for example buprofezin
  • spirodiclofen for example spirodiclofen, spirotetramat
  • flubendiamide for example flubendiamide, chloranthraniliprole (rynaxypyr), cyanthraniliprole (cyazypyr), the phthalamide compounds (R)-3-Chlor-N1 - ⁇ 2-methyl-4-[1 ,2,2,2 -tetrafluor-1 - (trifluormethyl)ethyl]phenyl ⁇ -N2-(1 -methyl-2-methylsulfonylethyl)phthalamid or (S)-3-Chlor-N1 - ⁇ 2-methyl-4-[1 ,2,2,2 -tetrafluor-1 -(trifluormethyl)ethyl]phenyl ⁇ -N2-(1 -methyl-2- methylsulfonylethyl)phthalamid (both known from WO 2007/101540), 3-bromo-N- ⁇ 2-bromo-4- chloro-6-[(1 -cyclopropylethyl)carbamoyl]phenyl ⁇ -1
  • M-25 Others for example afidopyropen, flumetoquin, 2-(5-ethylsulfinyl-2-fluoro-4-methyl- phenyl)-5-methyl-1 ,2,4-triazol-3-amine (known from WO 06/043635), 1 -(5-ethylsulfinyl-2,4- dimethyl-phenyl)-3-methyl-1 ,2,4-triazole (known from WO 06/043635.), metaldehyde; and M-26 Bacillus firmus, Bacillus firmus CNCM 1-1582.
  • inventive mixtures especially useful for seed and/or soil treatment are those comprising compound II and one insecticidal compound IB selected from momfluorothrin; 1 -[(6- chloro-3-pyridyl)methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine; 1 -[(E)-[2-(4-cyanophenyl)-1 - [3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea; N2-(1 -cyano- 1 -methyl-ethyl)-N 1 -(2,4-dimethylphenyl)-3-iodo-phthalamide, 3-chloro-N2-(1 -cyano-1 -methyl- ethyl)-N1 -(2,4-dimethylphenyl)phthalamide, 2-(3-chloro-2-pyridyl)--
  • ylamino)ethyl]naphthalene-1 -carboxamide 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H- isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide and 4-[5-(3,5- dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 -oxothietan-3-yl)benzami
  • Preferred inventive mixtures are those comprising compound II and compound I D selected from the group consisting of Bacillus subtilis MBI600 having the accession number NRRL B-50595, Bacillus pumilus I NR7 having the accession number NRRL B-50153 or NRRL B-50185 and Bacillus simplex strain ABU 288 having the accession number NRRL B-5034 and Tri
  • More preferred inventive mixtures are those comprising compound II and fungicidal compound IA are displayed in Table 1A:
  • mixtures N-1 to N-120 comprising Azospirillum brasilense as compound II instead of "A” and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures X-1 to X-120 comprising Azospirillum brasilense strain BR 1 1005 (SP 245) as compound II instead of "A” and compound IA corresponding to M- 1 to M-120 as defined in Table 1A.
  • mixtures 0-1 to 0-120 comprising Azospirillum haloprae- ferens as compound II instead of "A” and compound I A corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures P-1 to P-120 comprising Azospirillum lipoferum as compound II instead of "A” and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures Q-1 to Q-120 comprising Azospirillum ama- zonense as compound II instead of "A” and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures R-1 to R-120 comprising Azospirillum irakense as compound II instead of "A” and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures S-1 to S-120 comprising A. amazonense BR
  • mixtures T-1 to T-120 comprising A. brasilense AZ39 as compound II instead of "A" and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • mixtures U-1 to U-120 comprising A. brasilense BR 1 1002 as compound II instead of "A" and compound IA corresponding to M-1 to M-120 as defined in Table 1A.
  • Table 1 A-10
  • mixtures V-1 to V-120 comprising A. brasilense XOH as compound II instead of "A" and compound IA corresponding to M-1 to M-120 as defined in Ta- ble 1A.
  • mixtures W-1 to W-120 comprising A. Iipoferum BR 1 1646 (Sp31 ) as compound I I instead of "A” and compound IA corresponding to M-1 to M-120 as de- fined in Table 1 A.
  • mixtures ZN-1 to ZN-89 comprising Azospirillum brasilense as compound I I instead of "A” and compound I B corresponding to M'-1 to M'-89 as de- fined in Table 1 B.
  • mixtures ZX-1 to ZX-89 comprising Azospirillum brasilense strain BR 1 1005 (SP 245) as compound I I instead of "A” and compound I B corresponding to M'- 1 to M'-89 as defined in Table 1 B.
  • mixtures ZO-1 to ZO-89 comprising Azospirillum halo- praeferens as compound I I instead of "A" and compound IB corresponding to M'-1 to I -89 as defined in Table 1 B.
  • mixtures ZP-1 to ZP-89 comprising Azospirillum lipoferum as compound II instead of "A” and compound I B corresponding to M'-1 to M'-89 as defined in Table 1 B.
  • mixtures ZQ-1 to ZQ-89 comprising Azospirillum ama- zonense as compound I I instead of "A” and compound I B corresponding to M'-1 to M'-89 as defined in Table 1 B.
  • mixtures ZR-1 to ZR-89 comprising Azospirillum irakense as compound I I instead of "A” and compound I B corresponding to M'-1 to M'-89 as defined in Table 1 B.
  • Table 1 B-07 Equally more preferred mixtures are mixtures ZS-1 to ZS-89, comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A" and compound IB corresponding to M'-1 to I -89 as defined in Table 1 B.
  • Table 1 B-08 Equally more preferred mixtures are mixtures ZS-1 to ZS-89, comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A" and compound IB corresponding to M'-1 to I -89 as defined in Table 1 B.
  • Table 1 B-08 Equally more preferred mixtures are mixtures ZS-1 to ZS-89, comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A" and compound IB corresponding to M'-1 to I -89 as defined in Table 1 B.
  • Table 1 B-08 Equally more preferred mixtures are mixtures ZS-1 to ZS-89, comprising A. amazonense BR 1 1 140 (
  • mixtures ZT-1 to ZT-89 comprising A. brasilense AZ39 as compound II instead of "A" and compound IB corresponding to M'-1 to IW-89 as defined in Table 1 B.
  • mixtures ZU-1 to ZU-89 comprising A. brasilense BR 1 1002 as compound II instead of "A" and compound IB corresponding to M'-1 to IW-89 as defined in Table 1 B.
  • Table 1 B-10
  • mixtures ZV-1 to ZV-89 comprising A. brasilense XOH as compound II instead of "A" and compound IB corresponding to IW-1 to IW-89 as defined in Table 1 B.
  • Equally more preferred mixtures are mixtures ZW-1 to ZW-89, comprising A. lipoferum BR 1 1646 (Sp31 ) as compound II instead of "A" and compound IB corresponding to IW-1 to IW-89 as defined in Table 1 B.
  • Equally preferred inventive mixtures are those comprising compound II and compound IC having plant growth regulating activity displayed in Table 1 C:
  • prohexadione pro- A
  • inventive mixtures especially useful for seed and soil treatment are those comprising compound II and compound IC having plant growth regulating activity selected from chlormequat (chlormequat chloride), choline chloride, cyclanilide, dimethipin, ethephon, forchlorfenuron, gibberellic acid, maleic hydrazide, mepiquat (mepiquat chloride), 1 - methylcyclopropene (1 -MCP), prohexadione (prohexadione calcium), pthidiazuron and trinexapac-ethyl.
  • chlormequat chlormequat chloride
  • choline chloride choline chloride
  • cyclanilide dimethipin
  • ethephon dimethipin
  • forchlorfenuron gibberellic acid
  • maleic hydrazide mepiquat (mepiquat chloride)
  • 1 -MCP 1 - methylcyclopropene
  • mixtures CA-1 to CA-35 comprising A. brasilense as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as defined in Table 1 C.
  • mixtures CB-1 to CB-35 comprising A. brasilense BR 1 1005 (SP 245) as compound II instead of "A" and compound IC corresponding to M"-1 to M" 35 as defined in Table 1 C.
  • mixtures CC-1 to CC-35 comprising A. halopraeferens as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as defined in Table 1 C.
  • Table 1 C-04
  • mixtures CD-1 to CD-35 comprising A. Iipoferum as compound II instead of "A” and compound IC corresponding to M"-1 to M"-35 as defined in Table 1 C.
  • mixtures CE-1 to CE-35 comprising A. amazonense as compound II instead of "A” and compound IC corresponding to M"-1 to M"-35 as defined in Ta- ble l C.
  • mixtures CF-1 to CF-35 comprising A. irakense as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as defined in Table 1 C.
  • mixtures CG-1 to CG-35 comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A" and compound IC corresponding to M"-1 to M"- 109 as defined in Table 1 C.
  • mixtures CH-1 to CH-35 comprising A. brasilense AZ39 as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as defined in Ta- ble l C.
  • mixtures CJ-1 to CJ-35 comprising A. brasilense BR 1 1002 as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as de- fined in Table 1 C.
  • mixtures CK-1 to CK-35 comprising A. brasilense XOH as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as defined in Ta- ble l C.
  • mixtures CL-1 to CL-35 comprising A. Iipoferum BR 1 1646 (Sp31 ) as compound II instead of "A" and compound IC corresponding to M"-1 to M"-35 as de- fined in Table 1 C.
  • T. harzianum T-22 A 2,3-dimethyl-quinolin- C-93.
  • mixtures YN-1 to YN-95 comprising Azospirillum bra- silense as compound II instead of "A” and compound I A corresponding to C-1 to C-95 as defined in Table 2A.
  • Table 2A-02 Equally most preferred mixtures are mixtures YX-1 to YX-95, comprising Azospirillum brasilense strain BR 1 1005 (SP 245) as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • Table 2A-03 Equally most preferred mixtures are mixtures YX-1 to YX-95, comprising Azospirillum brasilense strain BR 1 1005 (SP 245) as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • mixtures YP-1 to YP-95 comprising Azospirillum lipoferum as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • Table 2A-05
  • mixtures YQ-1 to YQ-95 comprising Azospirillum ama- zonense as compound II instead of "A” and compound I A corresponding to C-1 to C-95 as defined in Table 2A.
  • mixtures YS-1 to YS-95 comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • mixtures YT-1 to YT-95 comprising A. brasilense AZ39 as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • mixtures YU-1 to YU-95 comprising A. brasilense BR
  • mixtures YV-1 to YV-95 comprising A. brasilense XOH as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • Table 2A-1 1 1
  • mixtures YW-1 to YW-95 comprising A. Iipoferum BR 1 1646 (Sp31 ) as compound II instead of "A” and compound IA corresponding to C-1 to C-95 as defined in Table 2A.
  • Equally most preferred mixtures are those comprising compound I I and compound I B displayed in Table 2B:
  • mixtures FN-1 to FN-59 comprising Azospirillum brasilense as compound I I instead of "A” and compound I B corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FX-1 to FX-59 comprising Azospirillum brasilense Strain BR 1 1005 (SP 245) as compound I I instead of "A” and compound I B corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FO-1 to FO-59 comprising Azospirillum haloprae- ferens as compound II instead of "A” and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures F P-1 to FP-59 comprising Azospirillum lipoferum as compound II instead of "A” and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FQ-1 to FQ-59 comprising Azospirillum ama- zonense as compound II instead of "A” and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FR-1 to FR-59 Equally most preferred mixtures are mixtures FR-1 to FR-59, Azospirillum irakense as compound II instead of "A" and compound I A corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FS-1 to FS-59 comprising A. amazonense BR 1 1 140 (SpY2T) as compound II instead of "A” and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FT-1 to FT-59 comprising A. brasilense AZ39 as compound II instead of "A" and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FU-1 to FU-59 comprising A. brasilense BR 1 1002 as compound II instead of "A" and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FV-1 to FV-59 comprising A. brasilense XOH as compound II instead of "A" and compound IB corresponding to C-1 to C-59 as defined in Table 2B.
  • mixtures FW-1 to FW-59 comprising A. lipoferum BR
  • the present invention also comprises mixtures of compound II and compound ID as displayed in Table D:
  • the present invention furthermore relates to mixtures comprising compound I, compound II and compound ID, wherein compound III is selected from the group consisting of Bacillus subtilis MBI600, Bacillus pumilus INR-7, Bacillus simplex strain ABU 288 and Trichoderma fertile strain JM41 R.
  • compound III is selected from the group consisting of Bacillus subtilis MBI600, Bacillus pumilus INR-7, Bacillus simplex strain ABU 288 and Trichoderma fertile strain JM41 R.
  • the present invention relates to synergistic mixtures comprising Azospirillum brasilense, and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum bra- silense strain BR 1 1005 (SP 245) and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum lipoferum, and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum amazonense, and one compound I A and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ira- kense and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum halo- praeferens and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense AZ39 and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense BR 1 1002 and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IA and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense, and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense strain BR 1 1005 (SP 245) and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum lipoferum, and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ama- zonense, and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ira- kense and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum halo- praeferens and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. amazonense BR 1 1 140 (SpY2T) and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense AZ39 and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense BR 1 1002 and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense, and one compound IB and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum brasilense strain BR 1 1005 (SP 245) and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum lipoferum, and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum amazonense, and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum ira- kense and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising Azospirillum halo- praeferens and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. amazonense
  • BR 1 1 140 (SpY2T) and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense AZ39 and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense BR
  • the present invention furthermore relates to synergistic mixtures comprising A. brasilense XOH and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to synergistic mixtures comprising A. lipoferum BR 1 1646 (Sp31 ) and one compound IC and compound ID as defined above.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 1 C-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus subtilis MBI600, and the combination of compounds I and II in each case corresponds to a row of table 2B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 A-07.ln particular, the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 1 C-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus pumilus INR-7, and the combination of compounds I and II in each case corresponds to a row of table 2B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1A-07.ln particular, the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of com- pounds I and II in each case corresponds to a row of table 1A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 C-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 C-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 C-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 1 C-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 1 C-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 2A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 2A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 2A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 2B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corre- sponds to a row of table 2B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Ba- cillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Bacillus simplex strain ABU-288, and the combination of compounds I and II in each case corresponds to a row of table 2B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 1 A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 1A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 A-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 B.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 B-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 1 B-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 B-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 B-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 1 C.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 C-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 C-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 C-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 1 C-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 1 C-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 1 C-1 1 .
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-01 .
  • the present invention furthermore relates to mixtures, wherein compound ID is
  • Trichoderma fertile strain JM41 R and the combination of compounds I and II in each case corresponds to a row of table 2A-02.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 2A-03.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 2A-04.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-05.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-06.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case cor- responds to a row of table 2A-07.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-08.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-09.
  • the present invention furthermore relates to mixtures, wherein compound ID is Trichoderma fertile strain JM41 R, and the combination of compounds I and II in each case corresponds to a row of table 2A-10.
  • the present invention furthermore relates to mixtures, wherein compound ID is

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention concerne des mélanges pesticides comprenant un composé biologique et au moins un fongicide, un insecticide ou un composé régulateur de croissance des plantes, tels que définis dans la description, ainsi que des utilisations respectives de ceux-ci en agriculture.
PCT/EP2013/073748 2012-11-23 2013-11-13 Mélanges pesticides WO2014079754A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP12194013.4 2012-11-23
EP12194013 2012-11-23
EP12194335 2012-11-27
EP12194335.1 2012-11-27
EP13187654.2 2013-10-08
EP13187654 2013-10-08

Publications (1)

Publication Number Publication Date
WO2014079754A1 true WO2014079754A1 (fr) 2014-05-30

Family

ID=49584730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/073748 WO2014079754A1 (fr) 2012-11-23 2013-11-13 Mélanges pesticides

Country Status (1)

Country Link
WO (1) WO2014079754A1 (fr)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104304313A (zh) * 2014-09-29 2015-01-28 青岛康合伟业商贸有限公司 一种含有辛硫磷、氟啶虫胺腈、呋虫胺和毒死蜱的高效杀虫剂
CN104322545A (zh) * 2014-09-30 2015-02-04 青岛康合伟业商贸有限公司 一种含有硫氟肟醚、氟啶虫胺腈、呋虫胺和毒死蜱的高效杀虫剂
WO2015118516A1 (fr) 2014-02-10 2015-08-13 Biofil Mikrobiológiai, Géntechnológiai És Biokémiai Kft. Bactéries de sols pour l'inoculation de sols stressés
CN104839182A (zh) * 2015-05-04 2015-08-19 山东省烟台市农业科学研究院 一种农药组合物及其应用
CN105181870A (zh) * 2015-09-24 2015-12-23 通标标准技术服务(上海)有限公司 一种测定蔬菜水果中噁霉灵残留物的方法
CN105532709A (zh) * 2016-01-25 2016-05-04 北京市农林科学院 一种含氟啶虫胺腈与烯酰吗啉的杀虫杀菌复配剂
CN105557715A (zh) * 2016-01-27 2016-05-11 江西省农业科学院植物保护研究所 一种含环虫酰肼的高效复配农药组合物
CN105660649A (zh) * 2016-03-31 2016-06-15 杭州宇龙化工有限公司 一种农业杀虫组合物及其用途
CN105685067A (zh) * 2016-03-31 2016-06-22 杭州宇龙化工有限公司 一种农业杀虫组合物及其用途
CN107365314A (zh) * 2016-05-11 2017-11-21 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
CN107664670A (zh) * 2017-08-08 2018-02-06 山东省农业科学院农业质量标准与检测技术研究所 玉米中种菌唑残留的超高效液相色谱‑串联质谱检测方法
US10212934B2 (en) 2014-06-25 2019-02-26 BASF Agro B.V. Pesticidal compositions
CN109392945A (zh) * 2018-11-05 2019-03-01 中国农业大学 一种有效防治棉蚜的复配杀虫剂及其应用
US10512267B2 (en) 2013-07-08 2019-12-24 BASF Agro, B.V. Compositions comprising a triazole compound and a biopesticide
US10519122B2 (en) 2013-01-09 2019-12-31 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10743535B2 (en) 2017-08-18 2020-08-18 H&K Solutions Llc Insecticide for flight-capable pests
US10759767B2 (en) 2012-12-20 2020-09-01 BASF Agro B.V. Compositions comprising a triazole compound
US10779536B2 (en) 2014-11-07 2020-09-22 Basf Se Pesticidal mixtures
US10905122B2 (en) 2016-03-16 2021-02-02 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals
US11241012B2 (en) 2016-03-16 2022-02-08 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean
US11425909B2 (en) 2016-03-16 2022-08-30 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010096494A (ko) * 2000-03-20 2001-11-07 조정일 축산 사료 첨가용 및 축분 처리용 미생물제제
US20060166825A1 (en) * 2005-01-27 2006-07-27 David Goulet Plant growth promoter
HUP0600717A2 (en) * 2006-09-12 2009-09-28 Chem Trade Kft Serum for soil which contains micro-organisms found in the nature
WO2010109436A1 (fr) * 2009-03-25 2010-09-30 Carepro Bioscience (P) Ltd Formulation microbienne conçue pour une utilisation étendue en agriculture
WO2012140177A1 (fr) * 2011-04-15 2012-10-18 Basf Se Procédé pour la culture de la canne à sucre

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010096494A (ko) * 2000-03-20 2001-11-07 조정일 축산 사료 첨가용 및 축분 처리용 미생물제제
US20060166825A1 (en) * 2005-01-27 2006-07-27 David Goulet Plant growth promoter
HUP0600717A2 (en) * 2006-09-12 2009-09-28 Chem Trade Kft Serum for soil which contains micro-organisms found in the nature
WO2010109436A1 (fr) * 2009-03-25 2010-09-30 Carepro Bioscience (P) Ltd Formulation microbienne conçue pour une utilisation étendue en agriculture
WO2012140177A1 (fr) * 2011-04-15 2012-10-18 Basf Se Procédé pour la culture de la canne à sucre

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FELICI C ET AL: "Single and co-inoculation of Bacillus subtilis and Azospirillum brasilense on Lycopersicon esculentum: Effects on plant growth and rhizosphere microbial community", APPLIED SOIL ECOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 40, no. 2, 2008, pages 260 - 270, XP024529977, ISSN: 0929-1393, [retrieved on 20080630], DOI: 10.1016/J.APSOIL.2008.05.002 *
MEHMET ÖGÜT ET AL: "Single and double inoculation with Azospirillum/Trichoderma: the effects on dry bean and wheat", BIOL. FERTIL. SOIL, vol. 41, 2005, pages 262 - 272, XP002694898 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10759767B2 (en) 2012-12-20 2020-09-01 BASF Agro B.V. Compositions comprising a triazole compound
US10981883B2 (en) 2013-01-09 2021-04-20 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10519122B2 (en) 2013-01-09 2019-12-31 BASF Agro B.V. Process for the preparation of substituted oxiranes and triazoles
US10512267B2 (en) 2013-07-08 2019-12-24 BASF Agro, B.V. Compositions comprising a triazole compound and a biopesticide
WO2015118516A1 (fr) 2014-02-10 2015-08-13 Biofil Mikrobiológiai, Géntechnológiai És Biokémiai Kft. Bactéries de sols pour l'inoculation de sols stressés
US10212934B2 (en) 2014-06-25 2019-02-26 BASF Agro B.V. Pesticidal compositions
CN104304313A (zh) * 2014-09-29 2015-01-28 青岛康合伟业商贸有限公司 一种含有辛硫磷、氟啶虫胺腈、呋虫胺和毒死蜱的高效杀虫剂
CN104322545A (zh) * 2014-09-30 2015-02-04 青岛康合伟业商贸有限公司 一种含有硫氟肟醚、氟啶虫胺腈、呋虫胺和毒死蜱的高效杀虫剂
US10779536B2 (en) 2014-11-07 2020-09-22 Basf Se Pesticidal mixtures
CN104839182A (zh) * 2015-05-04 2015-08-19 山东省烟台市农业科学研究院 一种农药组合物及其应用
CN105181870A (zh) * 2015-09-24 2015-12-23 通标标准技术服务(上海)有限公司 一种测定蔬菜水果中噁霉灵残留物的方法
CN105532709A (zh) * 2016-01-25 2016-05-04 北京市农林科学院 一种含氟啶虫胺腈与烯酰吗啉的杀虫杀菌复配剂
CN105557715A (zh) * 2016-01-27 2016-05-11 江西省农业科学院植物保护研究所 一种含环虫酰肼的高效复配农药组合物
US11425909B2 (en) 2016-03-16 2022-08-30 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits
US11241012B2 (en) 2016-03-16 2022-02-08 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean
US10905122B2 (en) 2016-03-16 2021-02-02 Basf Se Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals
CN105660649B (zh) * 2016-03-31 2018-04-10 杭州宇龙化工有限公司 一种农业杀虫组合物及其用途
CN105685067A (zh) * 2016-03-31 2016-06-22 杭州宇龙化工有限公司 一种农业杀虫组合物及其用途
CN105660649A (zh) * 2016-03-31 2016-06-15 杭州宇龙化工有限公司 一种农业杀虫组合物及其用途
CN107365314A (zh) * 2016-05-11 2017-11-21 国药集团国瑞药业有限公司 一种吡唑类化合物、其晶型及其制备方法
CN107664670A (zh) * 2017-08-08 2018-02-06 山东省农业科学院农业质量标准与检测技术研究所 玉米中种菌唑残留的超高效液相色谱‑串联质谱检测方法
CN107664670B (zh) * 2017-08-08 2019-12-03 山东省农业科学院农业质量标准与检测技术研究所 玉米中种菌唑残留的超高效液相色谱-串联质谱检测方法
US10743535B2 (en) 2017-08-18 2020-08-18 H&K Solutions Llc Insecticide for flight-capable pests
CN109392945B (zh) * 2018-11-05 2020-11-20 中国农业大学 一种有效防治棉蚜的复配杀虫剂及其应用
CN109392945A (zh) * 2018-11-05 2019-03-01 中国农业大学 一种有效防治棉蚜的复配杀虫剂及其应用

Similar Documents

Publication Publication Date Title
US11284623B2 (en) Pesticidal mixtures
AU2017204506B2 (en) Pesticidal mixtures
AU2013349928B2 (en) Pesticidal mixtures
AU2013349881B2 (en) Pesticidal mixtures
WO2014079754A1 (fr) Mélanges pesticides
WO2014079728A1 (fr) Mélanges pesticides
WO2014079772A1 (fr) Mélanges pesticides
WO2014079841A1 (fr) Mélanges pesticides
WO2014079724A1 (fr) Mélanges pesticides
WO2014079766A1 (fr) Mélanges pesticides
WO2014079774A1 (fr) Mélanges pesticides
WO2014079804A1 (fr) Mélanges pesticides
CA2885115A1 (fr) Melanges pesticides comprenant de l'acide jasmonique ou un derive de celui-ci
WO2014079813A1 (fr) Mélanges pesticides
WO2014079771A1 (fr) Mélanges pesticides
WO2014079730A1 (fr) Mélanges pesticides
WO2014079770A1 (fr) Mélanges pesticides
WO2014079769A1 (fr) Mélanges pesticides
WO2014079752A1 (fr) Mélanges pesticides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13791801

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13791801

Country of ref document: EP

Kind code of ref document: A1